Moffitt Researchers Discover New Targets for Approved Cancer Drug

Wednesday, October 11, 2017

A team of researchers at Moffitt Cancer Center used cellular drug screening, functional proteomics and computer-based modeling to determine whether drugs with well-known targets may be repurposed for use against other biological targets.

read more...